Explore more publications!

Latest News

Labels On
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
Info
Stock markets stage cautious recovery as blockbuster Nvidia sales stifle AI bubble fears

Stock markets stage cautious recovery as blockbuster Nvidia sales stifle AI bubble fears

Right-wing Daily Mail
Owner: Jonathan Harmsworth
Imexpharm named Vietnam’s best place to work in pharmaceutical industry

Imexpharm named Vietnam’s best place to work in pharmaceutical industry

Catalight's Proven Value-Based Care Model Succeeds in Improving Access and Cost Sustainability in the Behavioral Health Industry

Catalight's Proven Value-Based Care Model Succeeds in Improving Access and Cost Sustainability in the Behavioral Health Industry

Urgent warning issued over new highly contagious strain of flu

Urgent warning issued over new highly contagious strain of flu

<![CDATA[FDA Approves Sevabertinib in HER2-Mutated Nonsquamous NSCLC]]>

<![CDATA[FDA Approves Sevabertinib in HER2-Mutated Nonsquamous NSCLC]]>

<![CDATA[Physical Activity in Mid- and Late Life Linked to Markedly Lower Risk of Dementia ]]>

<![CDATA[Physical Activity in Mid- and Late Life Linked to Markedly Lower Risk of Dementia ]]>

EyePoint Announces Positive Recommendation for Pivotal Phase 3 Trials of Duravyu

EyePoint Announces Positive Recommendation for Pivotal Phase 3 Trials of Duravyu

SMT’s Hydra TAVR Valve Shows Strong Safety and Durability in 5-Year Follow-Up Study

SMT’s Hydra TAVR Valve Shows Strong Safety and Durability in 5-Year Follow-Up Study

'Bacteria pill' could replace colonoscopy for gut diseases, makers say

'Bacteria pill' could replace colonoscopy for gut diseases, makers say

<![CDATA[Weekly Dose Podcast: FDA Breakthrough in Acromegaly, Alcohol–Dementia Risk Clarified, Tirzepatide in Youth T2D, Precision Mood Gains, and Major Contraception Practice Insights]]>

<![CDATA[Weekly Dose Podcast: FDA Breakthrough in Acromegaly, Alcohol–Dementia Risk Clarified, Tirzepatide in Youth T2D, Precision Mood Gains, and Major Contraception Practice Insights]]>

Indeterminate Patient Care
Owner: Mike Hennessy Jr.
Imexpharm named Vietnam’s best place to work in pharmaceutical industry

Imexpharm named Vietnam’s best place to work in pharmaceutical industry

Catalight's Proven Value-Based Care Model Succeeds in Improving Access and Cost Sustainability in the Behavioral Health Industry

Catalight's Proven Value-Based Care Model Succeeds in Improving Access and Cost Sustainability in the Behavioral Health Industry

Urgent warning issued over new highly contagious strain of flu

Urgent warning issued over new highly contagious strain of flu

<![CDATA[FDA Approves Sevabertinib in HER2-Mutated Nonsquamous NSCLC]]>

<![CDATA[FDA Approves Sevabertinib in HER2-Mutated Nonsquamous NSCLC]]>

<![CDATA[Physical Activity in Mid- and Late Life Linked to Markedly Lower Risk of Dementia ]]>

<![CDATA[Physical Activity in Mid- and Late Life Linked to Markedly Lower Risk of Dementia ]]>

EyePoint Announces Positive Recommendation for Pivotal Phase 3 Trials of Duravyu

EyePoint Announces Positive Recommendation for Pivotal Phase 3 Trials of Duravyu

SMT’s Hydra TAVR Valve Shows Strong Safety and Durability in 5-Year Follow-Up Study

SMT’s Hydra TAVR Valve Shows Strong Safety and Durability in 5-Year Follow-Up Study

'Bacteria pill' could replace colonoscopy for gut diseases, makers say

'Bacteria pill' could replace colonoscopy for gut diseases, makers say

<![CDATA[Weekly Dose Podcast: FDA Breakthrough in Acromegaly, Alcohol–Dementia Risk Clarified, Tirzepatide in Youth T2D, Precision Mood Gains, and Major Contraception Practice Insights]]>

<![CDATA[Weekly Dose Podcast: FDA Breakthrough in Acromegaly, Alcohol–Dementia Risk Clarified, Tirzepatide in Youth T2D, Precision Mood Gains, and Major Contraception Practice Insights]]>

Stock markets stage cautious recovery as blockbuster Nvidia sales stifle AI bubble fears

Stock markets stage cautious recovery as blockbuster Nvidia sales stifle AI bubble fears

Show More

Video Stories

YouTube video thumbnail: Sen. Markwayne Mullin: We Shouldn’t be Subsidizing Highly Profitable Health Insurance Companies
Play
Sen. Markwayne Mullin: We Shouldn’t be Subsidizing Highly Profitable Health Insurance Companies
YouTube video thumbnail: What Americans' top Health Care Concerns are Heading Into 2026
Play
What Americans' top Health Care Concerns are Heading Into 2026
YouTube video thumbnail: What Factors are Contributing to Declining U.S. Happiness?
Play
What Factors are Contributing to Declining U.S. Happiness?
YouTube video thumbnail: Camp for Children With Autoimmune Diseases Allows Kids to Just be Kids
Play
Camp for Children With Autoimmune Diseases Allows Kids to Just be Kids

Video Title

Press Releases

Single prime editing system could potentially treat multiple genetic diseases

Single prime editing system could potentially treat multiple genetic diseases

Navigating weight loss: When to consider bariatric surgery after GLP-1 therapy

Navigating weight loss: When to consider bariatric surgery after GLP-1 therapy

FDA Pilots Faster Clarifications to Meeting Minutes

FDA Pilots Faster Clarifications to Meeting Minutes

Drug Trials Snapshots: MODEYSO

Drug Trials Snapshots: MODEYSO

FDA grants traditional approval to tarlatamab-dlle for extensive stage small cell lung cancer

FDA grants traditional approval to tarlatamab-dlle for extensive stage small cell lung cancer

FDA grants accelerated approval to sevabertinib for non-squamous non-small cell lung cancer

FDA grants accelerated approval to sevabertinib for non-squamous non-small cell lung cancer

FDA grants traditional approval to daratumumab and hyaluronidase-fihj for newly diagnosed light chain amyloidosis

FDA grants traditional approval to daratumumab and hyaluronidase-fihj for newly diagnosed light chain amyloidosis

Drug Trials Snapshots: ANZUPGO

Drug Trials Snapshots: ANZUPGO

Drug Trials Snapshots: SEPHIENCE

Drug Trials Snapshots: SEPHIENCE

Single prime editing system could potentially treat multiple genetic diseases

Single prime editing system could potentially treat multiple genetic diseases

Navigating weight loss: When to consider bariatric surgery after GLP-1 therapy

Navigating weight loss: When to consider bariatric surgery after GLP-1 therapy

FDA Pilots Faster Clarifications to Meeting Minutes

FDA Pilots Faster Clarifications to Meeting Minutes

Drug Trials Snapshots: MODEYSO

Drug Trials Snapshots: MODEYSO

FDA grants traditional approval to tarlatamab-dlle for extensive stage small cell lung cancer

FDA grants traditional approval to tarlatamab-dlle for extensive stage small cell lung cancer

FDA grants accelerated approval to sevabertinib for non-squamous non-small cell lung cancer

FDA grants accelerated approval to sevabertinib for non-squamous non-small cell lung cancer

FDA grants traditional approval to daratumumab and hyaluronidase-fihj for newly diagnosed light chain amyloidosis

FDA grants traditional approval to daratumumab and hyaluronidase-fihj for newly diagnosed light chain amyloidosis

Drug Trials Snapshots: ANZUPGO

Drug Trials Snapshots: ANZUPGO

Drug Trials Snapshots: SEPHIENCE

Drug Trials Snapshots: SEPHIENCE

Show More
Your brand’s story is being written — with or without you.
We’re the leading press release service for mid-sized businesses & organizations built for the AI era.
Learn more

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions